Echocardiography in Men With Erectile Dysfunction
Prevalence and Risk Factors Associated With Cardiovascular Comorbidity in Men With Erectile Dysfunction
1 other identifier
observational
386
1 country
1
Brief Summary
Cardiovascular disease is the leading cause of morbidity and mortality in the world. To curb disease development, there is, therefore, a need to identify more people at increased risk. This can be done by advanced echocardiography, where the exact contraction pattern and dimensions of the heart are measured. One group of patients who are already considered to be at increased risk for later development of heart disease are men with erectile dysfunction. The investigators goal is to study the early detection of cardiac dysfunction in men with erectile dysfunction using both conventional and advanced echocardiography to analyze the possibility of preventing serious cardiovascular disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2022
CompletedStudy Start
First participant enrolled
March 1, 2022
CompletedFirst Posted
Study publicly available on registry
March 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2032
ExpectedJanuary 16, 2024
January 1, 2024
1.8 years
February 2, 2022
January 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (21)
Number of reported cardiac arrest through medical records
1 year
Number of reported cardiac arrest through medical records
5 years
Number of reported cardiac arrest through medical records
10 years
Number of reported hospital admission with heart failure through medical records
1 year
Number of reported hospital admission with heart failure through medical records
5 years
Number of reported hospital admission with heart failure through medical records
10 years
Number of reported peripheral artery disease through medical records
Registration of: Cholesterol levels, blood pressure, claudication and ankle brachial index (ABI).
1 year
Number of reported peripheral artery disease through medical records
Registration of: Cholesterol levels, blood pressure, claudication and ankle brachial index (ABI).
5 years
Number of reported peripheral artery disease through medical records
Registration of: Cholesterol levels, blood pressure, claudication and ankle brachial index (ABI).
10 years
Number of reported coronary heart disease through medical records
Registration of: Coronary angiography
1 year
Number of reported coronary heart disease through medical records
Registration of: Coronary angiography
5 years
Number of reported coronary heart disease through medical records
Registration of: Coronary angiography
10 years
Number of reported hospital admission with acute myocardial infarction through medical records
1 year
Number of reported hospital admission with acute myocardial infarction through medical records
5 years
Number of reported hospital admission with acute myocardial infarction through medical records
10 years
Number of reported angina pectoris through medical records
1 year
Number of reported angina pectoris through medical records
5 years
Number of reported angina pectoris through medical records
10 years
Number of reported ischemic heart disease through medical records
1 year
Number of reported ischemic heart disease through medical records
5 years
Number of reported ischemic heart disease through medical records
10 years
Secondary Outcomes (3)
Number of reported all cause mortality
1 year
Number of reported all cause mortality
5 years
Number of reported all cause mortality
10 years
Interventions
The echocardiography will be performed with a GE Vingmed UltrasoundÃs Vivid9 (Horten, Norway). All subjects are examined with color TDI, 2-dimensional and M-mode echocardiography, conventional spectral Doppler, 2DSTE, and where possible 4D Echocardiography in the left lateral decubitus position.
Eligibility Criteria
Patients will be invited from the Urology outpatient clinic at Gentofte Hospital.
You may not qualify if:
- Patients not able to cooperate
- Patients unable to understand and sign "informed consent"
- Previous pelvic surgery (including prostatectomy, cystectomy and rectal surgery)
- Neurological diseases (e.g. multiple sclerosis, spinal cord injury)
- ED following pelvic trauma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Urological Research Unit
Herlev, Capital Region, 2730, Denmark
Biospecimen
Whole blood
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 2, 2022
First Posted
March 17, 2022
Study Start
March 1, 2022
Primary Completion
January 5, 2024
Study Completion (Estimated)
March 1, 2032
Last Updated
January 16, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share